Completed PHASE1 INTERVENTIONAL 2-arm NCT00545857

Effect of Pioglitazone on the Course of New Onset Type 1 Diabetes Mellitus

Sponsor: Stony Brook University

Interventions Placebo control pioglitazone

Updated 5 times since 2017 Last updated: May 30, 2012 Started: Jun 30, 2002 Primary completion: May 31, 2012 Completion: May 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Type 1 Diabetes Mellitus, this trial is completed. The trial is conducted by Stony Brook University and has accumulated 5 data snapshots since 2002. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Jan 2021 — Jul 2024 [monthly]

Completed PHASE1
Jun 2018 — Jan 2021 [monthly]

Completed PHASE1
Jan 2017 — Jun 2018 [monthly]

Completed PHASE1

First recorded

Jun 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Stony Brook University

Data source: Stony Brook University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Stony Brook, United States